Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development

Bioconjugate Chemistry

Volumn 8, Issue 4, 1997, Pages 585-594

  Karacay, Habibe ^a   Sharkey, Robert M ^b   Govindan, Serengulam V ^a   McBride, William J ^a   Goldenberg, David M ^b   Hansen, Hans J ^a   Griffiths, Gary L ^a  

^a IMMUNOMEDICS INC   (United States)

^b GARDEN STATE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ANTIGENS; BLOOD; COENZYMES; COVALENT BONDS; DISEASES; MONOCLONAL ANTIBODIES; PEPTIDES; RADIOISOTOPES; SIZE EXCLUSION CHROMATOGRAPHY; SULFUR COMPOUNDS;

ANTIBODY CONJUGATE; CARCINOEMBRYONIC ANTIGEN; CIRCULATION TIME; CROSS LINKING; GALACTOSE RESIDUES; LOCALISATION; PROPERTY; RADIOIMMUNOTHERAPY; SH GROUPS; STREPTAVIDIN;

TUMORS;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS MUSCULUS;

EID: 0031194358     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970102n     Document Type: Article

References (46)

1. Bamias, A., and Epenetos, A. A. (1992) Two-step strategies for the diagnosis and treatment of cancer with bioconjugates. Antibody, Immunoconjugates, Radiopharm. 5, 385-395.
2. Goodwin, D. A., Meares, C. F., McCall, M. J., McTigue, M., and Chaovapong, W. (1988) Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. J. Nucl. Med. 29, 226-234.
3. Stickney, D. R., Anderson, L. D., Slater, J. B., Ahlem, C. N., Kirk, G. A., Schweighardt, S. A., and Frincke, J. M. (1991) Bifunctional antibody: A binary radiopharmaceutical delivery system for imaging colorectal carcinoma. Cancer Res. 51, 6650-6655.
4. Hawkins, G. A., McCabe, R. P., Kim, C.-H., Subramanian, R., Bredehorst, R., McCullers, G. A., Vogel, C.-W., Hanna, M. G., Jr., and Pomata, N. (1993) Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system. Cancer Res. 53, 2368-2373.
5. Bos, E. S., Kuijpers, W. H. A., Meesters-Winters, M., Pham, D. T., deHaan, A. S., van Doormalen, A. M., Kasperson, F. M., van Boeckel, C. A. A., and Gougeon-Bertrand, F. (1994) In vitro evaluation of DNA-DNA hybridization as a two-step approach in radioimmunotherapy of cancer. Cancer Res. 54, 3479-3486.
6. Hnatowich, D. J., Virzi, F., and Rusckowski, M. (1987) Investigations of avidin and biotin for imaging applications. J. Nucl. Med. 28, 1294-1302.
7. Paganelli, G., Pervez, S., Siccardi, A. G., Rowlinson, G., Deleide, G., Chiolerio, F., Malcovati, M., Scassellati, G. A., and Epenetos, A. A. (1990) Intraperitoneal radiolocalization of tumors pre-targeted by biotinylated monoclonal antibodies. Int. J. Cancer 45, 1184-1189.
8. Axworthy, D. B., Theodore, L. J., Gustavson, L. M., and Reno, J. M. (1993) Pretargeting methods and compounds. International Patent Application WO 93/25240.
9. Axworthy, D. B., Fritzberg, A. R., Hylarides, M. D., Mallet, R., Theodore, L. J., Gustavson, L., Su, F.-M., Beamuier, P. L., and Reno, J. M. (1995) Durable complete remissions of breast, lung and colon tumor xenografts with a single dose of pretargeted Y-90 in a mouse model. J. Nucl. Med. 36, 217P (abstract).
10. Saga, T., Weinstein, J. N., Jeong, J. M., Heya, T., Lee, J. T., Le, N., Paik, C. H., Sung, C., and Neuman, R. D. (1994) Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin. Cancer Res. 54, 2160-2165.
11. Sung, C., van Osdol, W. W., Saga, T., Neumann, R. D., Dedrick, R. L., and Weinstein, J. L. (1994) Streptavidin distribution in metastatic tumors pretargeted with a biotinylated monoclonal antibody: Theoratical and experimental pharmacokinetics. Cancer Res. 54, 2166-2175.
12. 2 fragments of an anti-tumor monoclonal antibody. Br. J. Cancer 71, 18-24.
13. Paganelli, G., Chinol, M., Grana, C., De Cicco, C., Cremonesi, M., Meares, C. F., Franceschini, R., Tarditi, L., and Siccardi, A. G. (1995) Optimization of the three-step pretargeting approach for diagnosis and therapy in cancer patients. J. Nucl. Med. 36, 225P (abstract).
14. Breitz, H., Ratliff, B., Reno, J., Axworthy, D., Fritzberg, A., Su, F.-M., Appelbaum, J., Kunz, S., Seiler, C., and Weiden, P. (1995) Performance of antibody streptavidin pretargeting in patients: Initial results. J. Nucl. Med. 36, 225P (abstract).
15. Pimm, M. V., Fells, H. F., Perkins, A. C., and Baldwin, R. W. (1988) Iodine-131 and indium-111 labeled avidin and streptavidin for pre-targeted immunoscintigraphy with biotinylated anti-tumor monoclonal antibody. Nucl. Med. Commun. 9, 931-941.
16. 111In]biocytin to cultured ovarian adenocarcinoma cells using covalent monoclonal antibody-streptavidin conjugates. Appl. Radiat. Isot. 43, 1399-1402.
17. Virzi, F., Fritz, B., Rusckowski, M., Gionet, M., Misra, H., and Hnatowich, D. J. (1991) New indium-111 labeled biotin derivatives for improved immunotargeting. Nucl. Med. Biol. 18, 719-726.
18. Del Rosario, R. B., Baron, L. E., Lawton, R. G., and Wahl, R. (1992) Streptavidin-biotinylated IgG conjugates: A simple procedure for reducing polymer formation. Nucl. Med. Biol. 19, 417-421.
19. Rosebrough, S. F. (1993) Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin. Nucl. Med. Biol. 20, 663-668.
20. Khawli, L. A., Alauddin, M. M., Miller, G. K., and Epstein, A. L. (1993) Improved immunotargeting of tumors with biotinylated monclonal antibodies and radiolabeled streptavidin. Antibody, Immunoconjugates, Radiopharm. 6, 13-27.
21. Hnatowich, D. J., Fritz, B., Virzi, F., Mardirossian, G., and Rusckowski, M. (1993) Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody. Nucl. Med. Biol. 20, 189-195.
22. Kang, Y.-S., and Pardridge, W. M. (1994) Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate. J. Pharmacol. Exp. Ther. 269, 344-350.
23. Kobayashi, H., Sakahara, H., Hosono, M., Yao, Z.-S., Toyama, S., Endo, K., and Konishi, J. (1994) Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor. J. Nucl. Med. 35, 1677-1684.
24. Kobayashi, H., Sakahara, H., Endo, K., Hosono, M., Yao, Z.-S., Toyama, S., and Konishi, J. (1994) Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody. Jpn. J. Cancer Res. 86, 310-314.
25. Kassis, A. I., Jones, P. L., Matalka, K. Z., and Adelstein, S. J. (1996) Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin. J. Nucl. Med. 37, 343-352.
26. 111In-DTPA-biocytin. Nucl. Med. Biol. 23, 459-466.
27. Rusckowski, M., Fogarasi, M., Virzi, F., and Hnatowich, D. J. (1995) Influence of endogeneous biotin on the biodistribution of labelled derivatives in mice. Nucl. Med. Commun. 16, 38-46.
28. Ngai, W. M., Reilly, R. M., Polihronis, J., and Shpitz, B. (1995) In vitro and in vivo evaluation of streptavidin immunoconjugates of the second generation TAG-72 monoclonal antibody CC49. Nucl. Med. Biol. 22, 77-86.
29. Mattes, M. J. (1987) Biodistribution of antibodies after intraperitoneal or intravenous injection and effects of carbohydrate modifications. J. Natl. Cancer Inst. 79, 855-863.
30. Chauhan, J., and Dakshinamurti, K. J. (1986) Purification and characterization of human serum biotinidase. J. Biol. Chem. 261, 4268-4275.
31. Hansen, H. J., Goldenberg, D. M., Newman, E. S., Grebenau, R., and Sharkey, R. M. (1993) Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen. Cancer 71, 3478-3485.
32. Losman, M. J., Novick, K. E., Goldenberg, D. M., and Monestier, M. (1994) Mimickry of a carcinoembryonic antigen epitope by a rat monoclonal anti-idiotype antibody. Int. J. Cancer 56, 580-584.
33. Cummins, C. H., Rutter, E. W., and Fordyce, W. A. (1991) A convenient synthesis of bifunctional chelating agents based on diethylenetriaminepentaacetic acid and their coordination chemistry. Bioconjugate Chem. 2, 180-186.
34. Meares, C. F., McCall, M. J., Reardon, D. T., Goodwin, D. A, Diamanti, C. I., and McTigue, M. (1984) Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Anal. Biochem. 142, 68-78.
35. Penefsky, H. S. (1979) A centrifuged column procedure for the measurement of ligand binding by beef heart F1. Part G. Methods Enzymol. 56, 527-530.
36. Green, N. M. (1965) A specrophotometric assay for avidin and biotin based on binding of dyes by avidin. Biochem. J. 94, 23c-24c.
37. Savage, M. D., Mattson, G., Desai, S., Nielander, G. W., Morgensen, S., and Conklin, E. J. (1994) Assays for biotin and avidin. In Avidin-Biotin Chemistry: A Handbook, 2nd ed., pp 14-21, Pierce Chemical Co., Rockford, IL.
38. Sharkey, R. M., Karacay, H., Griffiths, G. L., Behr, T. M., Blumenthal, R., Mattes, M. J., Hansen, H. J., and Goldenberg, D. M. (1997) Development of a two-step avidin-biotin pretargeting method for radioimmunotherapy of colorectal cancer. Bioconjugate Chem. 8, 595-604.
39. Ellman, G. L. (1959) Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70-77.
40. 111In-labeled biotin. Antibody, Immunoconjugates, Radiopharm. 6, 97-109.
41. Lee, Y.-C., Stowell, C. P., and Krantz, M. J. (1976) 2-Imino-2-methoxyethyl-1-thioglycosides: New reagents for attaching sugars to proteins. Biochemistry 15, 3956-3963.
42. Stocks, S. J., Jones, A. J. M., Ramey, C. W., and Brooks, D. E. (1986) A fluorometric assay of the degree of modification of protein primary amines with polyethylene glycol. Anal. Biochem. 154, 232-234.
43. Li, M., and Meares, C. F. (1993) Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates. Bioconjugate Chem. 4, 275-283.
44. Bodansky, M. (1993) Principles of Peptide Synthesis, 2nd ed., pp 1-329, Springer-Verlag, Berlin.
45. Lewis, M. R., Raubitschek, A., and Shively, J. E. (1994) A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates. Bioconjugate Chem. 5, 565-576.
46. Greenwood, F. C., and Hunter, W. M. (1963) The preparation of I-131 labeled human growth hormone of high specific radioactivity. Biochem. J. 89, 114-123.